+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Adaptogens Market By Source, By End Use, By Application, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 320 Pages
  • September 2022
  • Region: Global
  • Allied Market Research
  • ID: 5712990
The adaptogens market size was valued at $10,320.2 million in 2021, and is projected to reach $20,328.6 million by 2031, registering a CAGR of 7.3% from 2022 to 2031. Adaptogen is meant to provide the herb that helps the body to regulate its natural metabolism and achieve balance. It helps in lowering mental stress.. Adaptogen plants are found in severe climates, for instance ashwagandha grows in desert. Ingredients such as ashwagandha and the holy basil have been linked to variety of health benefits including ashwagandha's ability to improve sleep. Ginseng, rohdiola, and schisandra are helpful in dealing with acute stress triggers in the body. Ginseng is used to improve the immune system of the body. Among all the adaptogens, ashwagandha has a major market share due to its health benefits.

Adaptogens are available in many forms such as adaptogen teas and the pre mixed powder consisting of adaptogens that can be consumed with food & in the form of capsules. Among all these forms, premix powder of adaptogen has a major market share due to its ability to be consumed with food as well as by mixing in liquid such as water.

The major factors that drive the growth of the adaptogens market are rise in amount of stress among consumers across the globe. In the study of American Institute of Stress, it was founded that about 73% people have stress, which impacts their mental health where as 48% of the people have trouble in sleeping due to stress.

According to the reports of global organization of stress, it was founded that almost 75% of the people experience moderate to high level of stress in the recent years. And to cure such kind of stress, adaptogen are prone to be a novel pharmaceutical solution to it. In addition, rise in demand for adaptogen from beverage industry and healthy food consumers, as adaptogen is available in powder form which help to reduce anxiety and increase the mental stability.Based on application, the adaptogen market is segmented into food & beverages, dietary & sports supplements, cosmetics, animal feed, and pharmaceuticals. Among all the segments food and beverages are holding the largest market share because the usage of adaptogen in meals and in the form of beverages such as tea as a supplement.

Asia-Pacific has a large share for the global adaptogen market. The growth is owing to the fact that the adaptogens are broadly used in ayurveda, which is widely practiced in India and ultimately results in substantial market growth in India. Other Asian countries such as South Korea and China are among the biggest users of adaptogens in traditional medicine. Moreover, rise in the demand from emerging economies and the increase in usage of adaptogens in food & beverage and dietary & sports supplements are going to create new opportunities for the adaptogen market manufacturers in the upcoming future. However rise in the cost of research and development activities acts as a major factor as a restraint and is expected to be a further challenge for the adaptogen market in the upcoming future.

The Adaptogens market is segmented on the basis of source, end use, application, and region. On the basis of source, the market is classified into ashwagandha, ginseng, astragalus, holy basil, rhodiola roseas, schisandra, adaptogenic mushrooms, and others. Depending on end use, it is classified into powder, capsules, teas & beverages, and others. On the basis of application, it is classified into food & beverages, dietary & sports supplements, cosmetics, animal feed, and pharmaceutical. By distribution channel, the market is classified into business to business, and business to consumer. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).

According to the market players, the major obstacle attributed to the pandemic was the disruption of the supply chain. Furthermore, all the distribution channels were nearly shut down in the first quarter of the pandemic. However, online channels such as Amazon and Flipkart were delivering products. The key players included in the adaptogens market analysis are Dabur India Ltd, Emami Limited, kairali ayurvedic group, Himalaya Wellness, Colgate-Palmolive Company, Procter & Gamble, Patanjali Ayurved Limited, Shahnaz Ayurveda Pvt. Ltd., Shree Baidyanath Ayurveda Bhawan Pvt. Ltd, Unilever, ENOMARK BIOTECH (ENOMARK HEALTHCARE), Riaan Wellness Pvt. Ltd., Givaudan International SA (NATUREX S.A.), PLT Health Solutions, and INDENA S.P.A.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the adaptogens market analysis from 2021 to 2031 to identify the prevailing adaptogens market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the adaptogens market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global adaptogens market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Source

  • Ashwagandha
  • Ginseng
  • Astragalus
  • Holy Basils
  • Rhodiola Roseas
  • Schisandra
  • Adaptogenic mushrooms
  • Others

By End Use

  • Powder
  • Capsules
  • Teas and Beverages
  • Others

By Application

  • Food and Beverages
  • Dietary and sports supplements
  • Cosmetics
  • Animal Feed
  • Pharmaceutical

By Distribution Channel

  • Business to Business
  • Business to Consumer
  • Sales channel
  • Supermarket and hypermarket
  • Specialty store
  • Pharmacies and drug stores
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Italy
  • Germany
  • France
  • Spain
  • The Netherlands
  • Switzerland
  • Rest Of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Rest Of Asia-Pacific
  • LAMEA
  • Latin America
  • Middle East
  • Africa

Key Market Players

  • Dabur India Ltd
  • Emami Limited
  • kairali ayurvedic group
  • Himalaya Wellness
  • Colgate-Palmolive Company
  • Procter & Gamble
  • Patanjali Ayurved Limited
  • Shahnaz Ayurveda Pvt. Ltd.
  • Shree Baidyanath Ayurveda Bhawan Pvt. Ltd
  • Unilever
  • ENOMARK BIOTECH (ENOMARK HEALTHCARE)
  • Riaan Wellness Pvt. Ltd.

○.Givaudan International SA (NATUREX S.A.)
  • PLT Health Solutions
  • INDENA S.P.A
Frequently Asked Questions about the Adaptogens Market

What is the estimated value of the Adaptogens Market?

The Adaptogens Market was estimated to be valued at $10320.2 million in 2021.

What is the growth rate of the Adaptogens Market?

The growth rate of the Adaptogens Market is 7.0%, with an estimated value of $20328.6 million by 2031.

What is the forecasted size of the Adaptogens Market?

The Adaptogens Market is estimated to be worth $20328.6 million by 2031.

Who are the key companies in the Adaptogens Market?

Key companies in the Adaptogens Market include Dabur India Ltd, Emami Limited, kairali ayurvedic group, Himalaya Wellness, Colgate, Palmolive Company, Procter & Gamble, Patanjali Ayurved Limited and Shree Baidyanath Ayurveda Bhawan Pvt. Ltd.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market

CHAPTER 4: ADAPTOGENS MARKET, BY SOURCE
4.1 Overview
4.1.1 Market size and forecast
4.2 Ashwagandha
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Ginseng
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Astragalus
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Holy Basils
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Rhodiola Roseas
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Schisandra
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
4.8 Adaptogenic mushrooms
4.8.1 Key market trends, growth factors and opportunities
4.8.2 Market size and forecast, by region
4.8.3 Market analysis by country
4.9 Others
4.9.1 Key market trends, growth factors and opportunities
4.9.2 Market size and forecast, by region
4.9.3 Market analysis by country

CHAPTER 5: ADAPTOGENS MARKET, BY END USE
5.1 Overview
5.1.1 Market size and forecast
5.2 Powder
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Capsules
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Teas and Beverages
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Others
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country

CHAPTER 6: ADAPTOGENS MARKET, BY APPLICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Food and Beverages
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Dietary and sports supplements
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Cosmetics
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Animal Feed
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
6.6 Pharmaceutical
6.6.1 Key market trends, growth factors and opportunities
6.6.2 Market size and forecast, by region
6.6.3 Market analysis by country

CHAPTER 7: ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL
7.1 Overview
7.1.1 Market size and forecast
7.2 Business to Business
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Business to Consumer
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.3.4 Business to Consumer Adaptogens Market by Sales channel
7.3.4.1 Supermarket and hypermarket Market size and forecast, by region
7.3.4.2 Specialty store Market size and forecast, by region
7.3.4.3 Pharmacies and drU.S.ores Market size and forecast, by region
7.3.4.4 Others Market size and forecast, by region

CHAPTER 8: ADAPTOGENS MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Source
8.2.3 North America Market size and forecast, by End Use
8.2.4 North America Market size and forecast, by Application
8.2.5 North America Market size and forecast, by Distribution Channel
8.2.5.1 North America Business to Consumer Adaptogens Market by Sales channel
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Source
8.2.6.1.2 Market size and forecast, by End Use
8.2.6.1.3 Market size and forecast, by Application
8.2.6.1.4 Market size and forecast, by Distribution Channel
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Source
8.2.6.2.2 Market size and forecast, by End Use
8.2.6.2.3 Market size and forecast, by Application
8.2.6.2.4 Market size and forecast, by Distribution Channel
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Source
8.2.6.3.2 Market size and forecast, by End Use
8.2.6.3.3 Market size and forecast, by Application
8.2.6.3.4 Market size and forecast, by Distribution Channel
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Source
8.3.3 Europe Market size and forecast, by End Use
8.3.4 Europe Market size and forecast, by Application
8.3.5 Europe Market size and forecast, by Distribution Channel
8.3.5.1 Europe Business to Consumer Adaptogens Market by Sales channel
8.3.6 Europe Market size and forecast, by country
8.3.6.1 UK
8.3.6.1.1 Market size and forecast, by Source
8.3.6.1.2 Market size and forecast, by End Use
8.3.6.1.3 Market size and forecast, by Application
8.3.6.1.4 Market size and forecast, by Distribution Channel
8.3.6.2 Italy
8.3.6.2.1 Market size and forecast, by Source
8.3.6.2.2 Market size and forecast, by End Use
8.3.6.2.3 Market size and forecast, by Application
8.3.6.2.4 Market size and forecast, by Distribution Channel
8.3.6.3 Germany
8.3.6.3.1 Market size and forecast, by Source
8.3.6.3.2 Market size and forecast, by End Use
8.3.6.3.3 Market size and forecast, by Application
8.3.6.3.4 Market size and forecast, by Distribution Channel
8.3.6.4 France
8.3.6.4.1 Market size and forecast, by Source
8.3.6.4.2 Market size and forecast, by End Use
8.3.6.4.3 Market size and forecast, by Application
8.3.6.4.4 Market size and forecast, by Distribution Channel
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Source
8.3.6.5.2 Market size and forecast, by End Use
8.3.6.5.3 Market size and forecast, by Application
8.3.6.5.4 Market size and forecast, by Distribution Channel
8.3.6.6 The Netherlands
8.3.6.6.1 Market size and forecast, by Source
8.3.6.6.2 Market size and forecast, by End Use
8.3.6.6.3 Market size and forecast, by Application
8.3.6.6.4 Market size and forecast, by Distribution Channel
8.3.6.7 Switzerland
8.3.6.7.1 Market size and forecast, by Source
8.3.6.7.2 Market size and forecast, by End Use
8.3.6.7.3 Market size and forecast, by Application
8.3.6.7.4 Market size and forecast, by Distribution Channel
8.3.6.8 Rest of Europe
8.3.6.8.1 Market size and forecast, by Source
8.3.6.8.2 Market size and forecast, by End Use
8.3.6.8.3 Market size and forecast, by Application
8.3.6.8.4 Market size and forecast, by Distribution Channel
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Source
8.4.3 Asia-Pacific Market size and forecast, by End Use
8.4.4 Asia-Pacific Market size and forecast, by Application
8.4.5 Asia-Pacific Market size and forecast, by Distribution Channel
8.4.5.1 Asia-Pacific Business to Consumer Adaptogens Market by Sales channel
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 China
8.4.6.1.1 Market size and forecast, by Source
8.4.6.1.2 Market size and forecast, by End Use
8.4.6.1.3 Market size and forecast, by Application
8.4.6.1.4 Market size and forecast, by Distribution Channel
8.4.6.2 Japan
8.4.6.2.1 Market size and forecast, by Source
8.4.6.2.2 Market size and forecast, by End Use
8.4.6.2.3 Market size and forecast, by Application
8.4.6.2.4 Market size and forecast, by Distribution Channel
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Source
8.4.6.3.2 Market size and forecast, by End Use
8.4.6.3.3 Market size and forecast, by Application
8.4.6.3.4 Market size and forecast, by Distribution Channel
8.4.6.4 South Korea
8.4.6.4.1 Market size and forecast, by Source
8.4.6.4.2 Market size and forecast, by End Use
8.4.6.4.3 Market size and forecast, by Application
8.4.6.4.4 Market size and forecast, by Distribution Channel
8.4.6.5 Australia
8.4.6.5.1 Market size and forecast, by Source
8.4.6.5.2 Market size and forecast, by End Use
8.4.6.5.3 Market size and forecast, by Application
8.4.6.5.4 Market size and forecast, by Distribution Channel
8.4.6.6 Indonesia
8.4.6.6.1 Market size and forecast, by Source
8.4.6.6.2 Market size and forecast, by End Use
8.4.6.6.3 Market size and forecast, by Application
8.4.6.6.4 Market size and forecast, by Distribution Channel
8.4.6.7 Thailand
8.4.6.7.1 Market size and forecast, by Source
8.4.6.7.2 Market size and forecast, by End Use
8.4.6.7.3 Market size and forecast, by Application
8.4.6.7.4 Market size and forecast, by Distribution Channel
8.4.6.8 Rest of Asia-Pacific
8.4.6.8.1 Market size and forecast, by Source
8.4.6.8.2 Market size and forecast, by End Use
8.4.6.8.3 Market size and forecast, by Application
8.4.6.8.4 Market size and forecast, by Distribution Channel
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Source
8.5.3 LAMEA Market size and forecast, by End Use
8.5.4 LAMEA Market size and forecast, by Application
8.5.5 LAMEA Market size and forecast, by Distribution Channel
8.5.5.1 LAMEA Business to Consumer Adaptogens Market by Sales channel
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Latin America
8.5.6.1.1 Market size and forecast, by Source
8.5.6.1.2 Market size and forecast, by End Use
8.5.6.1.3 Market size and forecast, by Application
8.5.6.1.4 Market size and forecast, by Distribution Channel
8.5.6.2 Middle East
8.5.6.2.1 Market size and forecast, by Source
8.5.6.2.2 Market size and forecast, by End Use
8.5.6.2.3 Market size and forecast, by Application
8.5.6.2.4 Market size and forecast, by Distribution Channel
8.5.6.3 Africa
8.5.6.3.1 Market size and forecast, by Source
8.5.6.3.2 Market size and forecast, by End Use
8.5.6.3.3 Market size and forecast, by Application
8.5.6.3.4 Market size and forecast, by Distribution Channel

CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments

CHAPTER 10: COMPANY PROFILES
10.1 Dabur India Ltd
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Emami Limited
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 kairali ayurvedic group
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 Himalaya Wellness
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Colgate-Palmolive Company
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Procter & Gamble
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Patanjali Ayurved Limited
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Shahnaz Ayurveda Pvt. Ltd.
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Shree Baidyanath Ayurveda Bhawan Pvt. Ltd
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Unilever
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
10.11 ENOMARK BIOTECH (ENOMARK HEALTHCARE)
10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Operating business segments
10.11.4 Product portfolio
10.11.5 Business performance
10.11.6 Key strategic moves and developments
10.12 Riaan Wellness Pvt. Ltd.
10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Operating business segments
10.12.4 Product portfolio
10.12.5 Business performance
10.12.6 Key strategic moves and developments
10.13 . Givaudan International SA (NATUREX S. A.)
10.13.1 Company overview
10.13.2 Company snapshot
10.13.3 Operating business segments
10.13.4 Product portfolio
10.13.5 Business performance
10.13.6 Key strategic moves and developments
10.14 PLT Health Solutions
10.14.1 Company overview
10.14.2 Company snapshot
10.14.3 Operating business segments
10.14.4 Product portfolio
10.14.5 Business performance
10.14.6 Key strategic moves and developments
10.15 INDENA S. P. A
10.15.1 Company overview
10.15.2 Company snapshot
10.15.3 Operating business segments
10.15.4 Product portfolio
10.15.5 Business performance
10.15.6 Key strategic moves and developments

List of Tables
Table 1. Global Adaptogens Market, by Source, 2021-2031 ($Million)
Table 2. Adaptogens Market, for Ashwagandha, by Region, 2021-2031 ($Million)
Table 3. Adaptogens Market for Ashwagandha, by Country, 2021-2031 ($Million)
Table 4. Adaptogens Market, for Ginseng, by Region, 2021-2031 ($Million)
Table 5. Adaptogens Market for Ginseng, by Country, 2021-2031 ($Million)
Table 6. Adaptogens Market, for Astragalus, by Region, 2021-2031 ($Million)
Table 7. Adaptogens Market for Astragalus, by Country, 2021-2031 ($Million)
Table 8. Adaptogens Market, for Holy Basils, by Region, 2021-2031 ($Million)
Table 9. Adaptogens Market for Holy Basils, by Country, 2021-2031 ($Million)
Table 10. Adaptogens Market, for Rhodiola Roseas, by Region, 2021-2031 ($Million)
Table 11. Adaptogens Market for Rhodiola Roseas, by Country, 2021-2031 ($Million)
Table 12. Adaptogens Market, for Schisandra, by Region, 2021-2031 ($Million)
Table 13. Adaptogens Market for Schisandra, by Country, 2021-2031 ($Million)
Table 14. Adaptogens Market, for Adaptogenic Mushrooms, by Region, 2021-2031 ($Million)
Table 15. Adaptogens Market for Adaptogenic Mushrooms, by Country, 2021-2031 ($Million)
Table 16. Adaptogens Market, for Others, by Region, 2021-2031 ($Million)
Table 17. Adaptogens Market for Others, by Country, 2021-2031 ($Million)
Table 18. Global Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 19. Adaptogens Market, for Powder, by Region, 2021-2031 ($Million)
Table 20. Adaptogens Market for Powder, by Country, 2021-2031 ($Million)
Table 21. Adaptogens Market, for Capsules, by Region, 2021-2031 ($Million)
Table 22. Adaptogens Market for Capsules, by Country, 2021-2031 ($Million)
Table 23. Adaptogens Market, for Teas and Beverages, by Region, 2021-2031 ($Million)
Table 24. Adaptogens Market for Teas and Beverages, by Country, 2021-2031 ($Million)
Table 25. Adaptogens Market, for Others, by Region, 2021-2031 ($Million)
Table 26. Adaptogens Market for Others, by Country, 2021-2031 ($Million)
Table 27. Global Adaptogens Market, by Application, 2021-2031 ($Million)
Table 28. Adaptogens Market, for Food and Beverages, by Region, 2021-2031 ($Million)
Table 29. Adaptogens Market for Food and Beverages, by Country, 2021-2031 ($Million)
Table 30. Adaptogens Market, for Dietary and Sports Supplements, by Region, 2021-2031 ($Million)
Table 31. Adaptogens Market for Dietary and Sports Supplements, by Country, 2021-2031 ($Million)
Table 32. Adaptogens Market, for Cosmetics, by Region, 2021-2031 ($Million)
Table 33. Adaptogens Market for Cosmetics, by Country, 2021-2031 ($Million)
Table 34. Adaptogens Market, for Animal Feed, by Region, 2021-2031 ($Million)
Table 35. Adaptogens Market for Animal Feed, by Country, 2021-2031 ($Million)
Table 36. Adaptogens Market, for Pharmaceutical, by Region, 2021-2031 ($Million)
Table 37. Adaptogens Market for Pharmaceutical, by Country, 2021-2031 ($Million)
Table 38. Global Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 39. Adaptogens Market, for Business to Business, by Region, 2021-2031 ($Million)
Table 40. Adaptogens Market for Business to Business, by Country, 2021-2031 ($Million)
Table 41. Adaptogens Market, for Business to Consumer, by Region, 2021-2031 ($Million)
Table 42. Adaptogens Market for Business to Consumer, by Country, 2021-2031 ($Million)
Table 43. Global Business to Consumer Adaptogens Market, by Sales Channel, 2021-2031 ($Million)
Table 44. Adaptogens Market, for Supermarket and Hypermarket, by Region, 2021-2031 ($Million)
Table 45. Adaptogens Market, for Specialty Store, by Region, 2021-2031 ($Million)
Table 46. Adaptogens Market, for Pharmacies and DrU.S.ores, by Region, 2021-2031 ($Million)
Table 47. Adaptogens Market, for Others, by Region, 2021-2031 ($Million)
Table 48. Adaptogens Market, by Region, 2021-2031 ($Million)
Table 49. North America Adaptogens Market, by Source, 2021-2031 ($Million)
Table 50. North America Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 51. North America Adaptogens Market, by Application, 2021-2031 ($Million)
Table 52. North America Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 53. North America Business to Consumer Adaptogens Market, by Sales Channel, 2021-2031 ($Million)
Table 54. North America Adaptogens Market, by Country, 2021-2031 ($Million)
Table 55. U.S. Adaptogens Market, by Source, 2021-2031 ($Million)
Table 56. U.S. Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 57. U.S. Adaptogens Market, by Application, 2021-2031 ($Million)
Table 58. U.S. Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 59. Canada Adaptogens Market, by Source, 2021-2031 ($Million)
Table 60. Canada Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 61. Canada Adaptogens Market, by Application, 2021-2031 ($Million)
Table 62. Canada Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 63. Mexico Adaptogens Market, by Source, 2021-2031 ($Million)
Table 64. Mexico Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 65. Mexico Adaptogens Market, by Application, 2021-2031 ($Million)
Table 66. Mexico Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 67. Europe Adaptogens Market, by Source, 2021-2031 ($Million)
Table 68. Europe Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 69. Europe Adaptogens Market, by Application, 2021-2031 ($Million)
Table 70. Europe Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 71. Europe Business to Consumer Adaptogens Market, by Sales Channel, 2021-2031 ($Million)
Table 72. Europe Adaptogens Market, by Country, 2021-2031 ($Million)
Table 73. UK Adaptogens Market, by Source, 2021-2031 ($Million)
Table 74. UK Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 75. UK Adaptogens Market, by Application, 2021-2031 ($Million)
Table 76. UK Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 77. Italy Adaptogens Market, by Source, 2021-2031 ($Million)
Table 78. Italy Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 79. Italy Adaptogens Market, by Application, 2021-2031 ($Million)
Table 80. Italy Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 81. Germany Adaptogens Market, by Source, 2021-2031 ($Million)
Table 82. Germany Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 83. Germany Adaptogens Market, by Application, 2021-2031 ($Million)
Table 84. Germany Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 85. France Adaptogens Market, by Source, 2021-2031 ($Million)
Table 86. France Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 87. France Adaptogens Market, by Application, 2021-2031 ($Million)
Table 88. France Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 89. Spain Adaptogens Market, by Source, 2021-2031 ($Million)
Table 90. Spain Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 91. Spain Adaptogens Market, by Application, 2021-2031 ($Million)
Table 92. Spain Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 93. the Netherlands Adaptogens Market, by Source, 2021-2031 ($Million)
Table 94. the Netherlands Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 95. the Netherlands Adaptogens Market, by Application, 2021-2031 ($Million)
Table 96. the Netherlands Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 97. Switzerland Adaptogens Market, by Source, 2021-2031 ($Million)
Table 98. Switzerland Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 99. Switzerland Adaptogens Market, by Application, 2021-2031 ($Million)
Table 100. Switzerland Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 101. Rest of Europe Adaptogens Market, by Source, 2021-2031 ($Million)
Table 102. Rest of Europe Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 103. Rest of Europe Adaptogens Market, by Application, 2021-2031 ($Million)
Table 104. Rest of Europe Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 105. Asia-Pacific Adaptogens Market, by Source, 2021-2031 ($Million)
Table 106. Asia-Pacific Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 107. Asia-Pacific Adaptogens Market, by Application, 2021-2031 ($Million)
Table 108. Asia-Pacific Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 109. Asia-Pacific Business to Consumer Adaptogens Market, by Sales Channel, 2021-2031 ($Million)
Table 110. Asia-Pacific Adaptogens Market, by Country, 2021-2031 ($Million)
Table 111. China Adaptogens Market, by Source, 2021-2031 ($Million)
Table 112. China Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 113. China Adaptogens Market, by Application, 2021-2031 ($Million)
Table 114. China Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 115. Japan Adaptogens Market, by Source, 2021-2031 ($Million)
Table 116. Japan Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 117. Japan Adaptogens Market, by Application, 2021-2031 ($Million)
Table 118. Japan Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 119. India Adaptogens Market, by Source, 2021-2031 ($Million)
Table 120. India Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 121. India Adaptogens Market, by Application, 2021-2031 ($Million)
Table 122. India Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 123. South Korea Adaptogens Market, by Source, 2021-2031 ($Million)
Table 124. South Korea Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 125. South Korea Adaptogens Market, by Application, 2021-2031 ($Million)
Table 126. South Korea Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 127. Australia Adaptogens Market, by Source, 2021-2031 ($Million)
Table 128. Australia Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 129. Australia Adaptogens Market, by Application, 2021-2031 ($Million)
Table 130. Australia Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 131. Indonesia Adaptogens Market, by Source, 2021-2031 ($Million)
Table 132. Indonesia Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 133. Indonesia Adaptogens Market, by Application, 2021-2031 ($Million)
Table 134. Indonesia Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 135. Thailand Adaptogens Market, by Source, 2021-2031 ($Million)
Table 136. Thailand Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 137. Thailand Adaptogens Market, by Application, 2021-2031 ($Million)
Table 138. Thailand Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 139. Rest of Asia-Pacific Adaptogens Market, by Source, 2021-2031 ($Million)
Table 140. Rest of Asia-Pacific Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 141. Rest of Asia-Pacific Adaptogens Market, by Application, 2021-2031 ($Million)
Table 142. Rest of Asia-Pacific Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 143. LAMEA Adaptogens Market, by Source, 2021-2031 ($Million)
Table 144. LAMEA Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 145. LAMEA Adaptogens Market, by Application, 2021-2031 ($Million)
Table 146. LAMEA Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 147. LAMEA Business to Consumer Adaptogens Market, by Sales Channel, 2021-2031 ($Million)
Table 148. LAMEA Adaptogens Market, by Country, 2021-2031 ($Million)
Table 149. Latin America Adaptogens Market, by Source, 2021-2031 ($Million)
Table 150. Latin America Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 151. Latin America Adaptogens Market, by Application, 2021-2031 ($Million)
Table 152. Latin America Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 153. Middle East Adaptogens Market, by Source, 2021-2031 ($Million)
Table 154. Middle East Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 155. Middle East Adaptogens Market, by Application, 2021-2031 ($Million)
Table 156. Middle East Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 157. Africa Adaptogens Market, by Source, 2021-2031 ($Million)
Table 158. Africa Adaptogens Market, by End Use, 2021-2031 ($Million)
Table 159. Africa Adaptogens Market, by Application, 2021-2031 ($Million)
Table 160. Africa Adaptogens Market, by Distribution Channel, 2021-2031 ($Million)
Table 161. Dabur India Ltd.: Company Snapshot
Table 162. Dabur India Ltd.: Operating Segments
Table 163. Dabur India Ltd.: Product Portfolio
Table 164. Dabur India Ltd.: Net Sales
Table 165. Dabur India Ltd.: Key Strategies
Table 166. Emami Limited: Company Snapshot
Table 167. Emami Limited: Operating Segments
Table 168. Emami Limited: Product Portfolio
Table 169. Emami Limited: Net Sales
Table 170. Emami Limited: Key Strategies
Table 171. Kairali Ayurvedic Group: Company Snapshot
Table 172. Kairali Ayurvedic Group: Operating Segments
Table 173. Kairali Ayurvedic Group: Product Portfolio
Table 174. Kairali Ayurvedic Group: Net Sales
Table 175. Kairali Ayurvedic Group: Key Strategies
Table 176. Himalaya Wellness: Company Snapshot
Table 177. Himalaya Wellness: Operating Segments
Table 178. Himalaya Wellness: Product Portfolio
Table 179. Himalaya Wellness: Net Sales
Table 180. Himalaya Wellness: Key Strategies
Table 181. Colgate-Palmolive Company: Company Snapshot
Table 182. Colgate-Palmolive Company: Operating Segments
Table 183. Colgate-Palmolive Company: Product Portfolio
Table 184. Colgate-Palmolive Company: Net Sales
Table 185. Colgate-Palmolive Company: Key Strategies
Table 186. Procter & Gamble: Company Snapshot
Table 187. Procter & Gamble: Operating Segments
Table 188. Procter & Gamble: Product Portfolio
Table 189. Procter & Gamble: Net Sales
Table 190. Procter & Gamble: Key Strategies
Table 191. Patanjali Ayurved Limited: Company Snapshot
Table 192. Patanjali Ayurved Limited: Operating Segments
Table 193. Patanjali Ayurved Limited: Product Portfolio
Table 194. Patanjali Ayurved Limited: Net Sales
Table 195. Patanjali Ayurved Limited: Key Strategies
Table 196. Shahnaz Ayurveda Pvt. Ltd.: Company Snapshot
Table 197. Shahnaz Ayurveda Pvt. Ltd.: Operating Segments
Table 198. Shahnaz Ayurveda Pvt. Ltd.: Product Portfolio
Table 199. Shahnaz Ayurveda Pvt. Ltd.: Net Sales
Table 200. Shahnaz Ayurveda Pvt. Ltd.: Key Strategies
Table 201. Shree Baidyanath Ayurveda Bhawan Pvt. Ltd.: Company Snapshot
Table 202. Shree Baidyanath Ayurveda Bhawan Pvt. Ltd.: Operating Segments
Table 203. Shree Baidyanath Ayurveda Bhawan Pvt. Ltd.: Product Portfolio
Table 204. Shree Baidyanath Ayurveda Bhawan Pvt. Ltd.: Net Sales
Table 205. Shree Baidyanath Ayurveda Bhawan Pvt. Ltd.: Key Strategies
Table 206. Unilever: Company Snapshot
Table 207. Unilever: Operating Segments
Table 208. Unilever: Product Portfolio
Table 209. Unilever: Net Sales
Table 210. Unilever: Key Strategies
Table 211. Enomark Biotech (Enomark Healthcare): Company Snapshot
Table 212. Enomark Biotech (Enomark Healthcare): Operating Segments
Table 213. Enomark Biotech (Enomark Healthcare): Product Portfolio
Table 214. Enomark Biotech (Enomark Healthcare): Net Sales
Table 215. Enomark Biotech (Enomark Healthcare): Key Strategies
Table 216. Riaan Wellness Pvt. Ltd.: Company Snapshot
Table 217. Riaan Wellness Pvt. Ltd.: Operating Segments
Table 218. Riaan Wellness Pvt. Ltd.: Product Portfolio
Table 219. Riaan Wellness Pvt. Ltd.: Net Sales
Table 220. Riaan Wellness Pvt. Ltd.: Key Strategies
Table 221. . Givaudan International SA (Naturex S. A.): Company Snapshot
Table 222. . Givaudan International SA (Naturex S. A.): Operating Segments
Table 223. . Givaudan International SA (Naturex S. A.): Product Portfolio
Table 224. . Givaudan International SA (Naturex S. A.): Net Sales
Table 225. . Givaudan International SA (Naturex S. A.): Key Strategies
Table 226. Plt Health Solutions: Company Snapshot
Table 227. Plt Health Solutions: Operating Segments
Table 228. Plt Health Solutions: Product Portfolio
Table 229. Plt Health Solutions: Net Sales
Table 230. Plt Health Solutions: Key Strategies
Table 231. Indena S. P. A: Company Snapshot
Table 232. Indena S. P. A: Operating Segments
Table 233. Indena S. P. A: Product Portfolio
Table 234. Indena S. P. A: Net Sales
Table 235. Indena S. P. A: Key Strategies

List of Figures
Figure 1. Adaptogens Market Segmentation
Figure 2. Adaptogens Market, 2021-2031
Figure 3. Adaptogens Market, 2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Adaptogens Mark.:Drivers, Restraints and Opportunities
Figure 12. Adaptogens Market, By Source, 2021(%)
Figure 13. Comparative Share Analysis of Ashwagandha Adaptogens Market, 2021-2031(%)
Figure 14. Comparative Share Analysis of Ginseng Adaptogens Market, 2021-2031(%)
Figure 15. Comparative Share Analysis of Astragalus Adaptogens Market, 2021-2031(%)
Figure 16. Comparative Share Analysis of Holy Basils Adaptogens Market, 2021-2031(%)
Figure 17. Comparative Share Analysis of Rhodiola Roseas Adaptogens Market, 2021-2031(%)
Figure 18. Comparative Share Analysis of Schisandra Adaptogens Market, 2021-2031(%)
Figure 19. Comparative Share Analysis of Adaptogenic Mushrooms Adaptogens Market, 2021-2031(%)
Figure 20. Comparative Share Analysis of Others Adaptogens Market, 2021-2031(%)
Figure 21. Adaptogens Market, By End Use, 2021(%)
Figure 22. Comparative Share Analysis of Powder Adaptogens Market, 2021-2031(%)
Figure 23. Comparative Share Analysis of Capsules Adaptogens Market, 2021-2031(%)
Figure 24. Comparative Share Analysis of Teas and Beverages Adaptogens Market, 2021-2031(%)
Figure 25. Comparative Share Analysis of Others Adaptogens Market, 2021-2031(%)
Figure 26. Adaptogens Market, By Application, 2021(%)
Figure 27. Comparative Share Analysis of Food and Beverages Adaptogens Market, 2021-2031(%)
Figure 28. Comparative Share Analysis of Dietary and Sports Supplements Adaptogens Market, 2021-2031(%)
Figure 29. Comparative Share Analysis of Cosmetics Adaptogens Market, 2021-2031(%)
Figure 30. Comparative Share Analysis of Animal Feed Adaptogens Market, 2021-2031(%)
Figure 31. Comparative Share Analysis of Pharmaceutical Adaptogens Market, 2021-2031(%)
Figure 32. Adaptogens Market, By Distribution Channel, 2021(%)
Figure 33. Comparative Share Analysis of Business to Business Adaptogens Market, 2021-2031(%)
Figure 34. Comparative Share Analysis of Business to Consumer Adaptogens Market, 2021-2031(%)
Figure 35. Adaptogens Market by Region, 2021
Figure 36. U.S. Adaptogens Market, 2021-2031($Million)
Figure 37. Canada Adaptogens Market, 2021-2031($Million)
Figure 38. Mexico Adaptogens Market, 2021-2031($Million)
Figure 39. Uk Adaptogens Market, 2021-2031($Million)
Figure 40. Italy Adaptogens Market, 2021-2031($Million)
Figure 41. Germany Adaptogens Market, 2021-2031($Million)
Figure 42. France Adaptogens Market, 2021-2031($Million)
Figure 43. Spain Adaptogens Market, 2021-2031($Million)
Figure 44. The Netherlands Adaptogens Market, 2021-2031($Million)
Figure 45. Switzerland Adaptogens Market, 2021-2031($Million)
Figure 46. Rest of Europe Adaptogens Market, 2021-2031($Million)
Figure 47. China Adaptogens Market, 2021-2031($Million)
Figure 48. Japan Adaptogens Market, 2021-2031($Million)
Figure 49. India Adaptogens Market, 2021-2031($Million)
Figure 50. South Korea Adaptogens Market, 2021-2031($Million)
Figure 51. Australia Adaptogens Market, 2021-2031($Million)
Figure 52. Indonesia Adaptogens Market, 2021-2031($Million)
Figure 53. Thailand Adaptogens Market, 2021-2031($Million)
Figure 54. Rest of Asia-Pacific Adaptogens Market, 2021-2031($Million)
Figure 55. Latin America Adaptogens Market, 2021-2031($Million)
Figure 56. Middle East Adaptogens Market, 2021-2031($Million)
Figure 57. Africa Adaptogens Market, 2021-2031($Million)
Figure 58. Top Winning Strategies, by Year
Figure 59. Top Winning Strategies, by Development
Figure 60. Top Winning Strategies, by Company
Figure 61. Product Mapping of Top 10 Players
Figure 62. Competitive Dashboard
Figure 63. Competitive Heatmap of Top 10 Key Players
Figure 64. Dabur India Lt.: Net Sales, ($Million)
Figure 65. Emami Limite.: Net Sales, ($Million)
Figure 66. Kairali Ayurvedic Grou.: Net Sales, ($Million)
Figure 67. Himalaya Wellnes.: Net Sales, ($Million)
Figure 68. Colgate-Palmolive Compan.: Net Sales, ($Million)
Figure 69. Procter & Gambl.: Net Sales, ($Million)
Figure 70. Patanjali Ayurved Limite.: Net Sales, ($Million)
Figure 71. Shahnaz Ayurveda Pvt. Ltd.: Net Sales, ($Million)
Figure 72. Shree Baidyanath Ayurveda Bhawan Pvt. Lt.: Net Sales, ($Million)
Figure 73. Unileve.: Net Sales, ($Million)
Figure 74. Enomark Biotech (Enomark Healthcare.: Net Sales, ($Million)
Figure 75. Riaan Wellness Pvt. Ltd.: Net Sales, ($Million)
Figure 76. .Givaudan International Sa (Naturex S.A..: Net Sales, ($Million)
Figure 77. Plt Health Solution.: Net Sales, ($Million)
Figure 78. Indena S.P..: Net Sales, ($Million)

Executive Summary

According to the report, “Adaptogens Market," the Adaptogens Market Size was valued at $10.3 billion in 2021, and is estimated to reach $20.3 billion by 2031, growing at a CAGR of 7.3% from 2022 to 2031.

Adaptogens are available in various different types, such as ashwagandha, ginseng, astragalus, holy basil, rhodiola rosea, schisandra, adaptogen mushrooms, and others, All these adaptogen herbs and mushrooms have great medicinal properties. These adaptogens can be consumed in different forms such as food & beverage, tea, and dietary & sport supplements. The hectic and stressful lifestyle of customers surges the demand for adaptogen, it helps individual’s body respond to stress, anxiety, fatigue, and overall wellbeing. In addition, adaptogens help to bring body back to a steady balance by managing both physical and mental stress.

Adaptogen herbs such as ashwagandha grows in the desert and rhodiola rosea in the Andes Mountains' highest peaks. Ingredients such as ashwagandha, rhodiola rosea, and holy basil have been linked to a variety of health benefits, including ashwagandha's ability to improve sleep and mental performance. These are easily available to customers in stores as well as online in different forms.

The adaptogen market is segmented into source, end use, application, distribution channel, and region. On the basis of source, the market is classified into ashwagandha, ginseng, astragalus, holy basil, rhodiola rosea, schisandra, adaptogen mushrooms, and others. Among these, the ashwagandha segment occupied the major share of the Adaptogens Market, and is projected to maintain its dominance during the Adaptogens Market Forecast period. The growth of the processed ashwagandha segment is attributed to nutrients and health benefits provided by it. However, the other Adaptogens Market Analysis segment is anticipated to grow in the future.

Depending on end use, the market is fragmented into powder, capsules, tea & beverage, and others. Among these, the conventional occupied the major Adaptogens Market Share, and is projected to maintain its dominance during the forecast period. This is attributed to its numerous benefits such as it is easy to blend with various liquids including milk, water, and coffee.

By application, the market is segregated into food & beverage, dietary & sports supplements, cosmetic, animal feed, and pharmaceutical. The food & beverage segment is anticipated to grow at the highest rate during the forecast period, it is attributed to the growth in preference for healthy eating habits among consumer and these adaptogen can be easily blended into different food & beverages.

As per distribution channel, the market is categorized into supermarkets & hypermarkets, specialty stores, online sales channel, and others. The specialty store channel is expanding at the fastest rate due to the discounts, vast selection, and unique shopping experience it offers.

In 2021, Asia-Pacific accounted for 31.7% in the global adaptogen market and is expected to maintain its dominance during the forecast period. However, North America and Europe are expected to possess the highest CAGRs of 8.0% and 7.7% respectively, owing to rise in health & fitness concerns among people and the increase in the popularity of adaptogens and their health benefits in these regions. With the Adaptogens Market Growth in consumer awareness about the several health benefits of adaptogen, its demand is expected to increase rapidly in Adaptogens Market Trends.

Owing to COVID-19, rise has been witnessed in the demand for healthy and nature- based food products such as adaptogens. The sales of various adaptogens have increased, as they are consumed by health-conscious people to maintain a healthy and stress-free lifestyle. In addition, after the COVID-19 pandemic, people are taking more precaution regarding food intake and prefer including Adaptogens Market Opportunities in their supplements.

The major players analyzed for global Adaptogens Industry are Dabur India Ltd, Emami Limited, kairali ayurvedic group, Himalaya Wellness, Colgate-Palmolive Company, Procter & Gamble, Patanjali Ayurved Limited, Shahnaz Ayurveda Pvt. Ltd., Shree Baidyanath Ayurveda Bhawan Pvt. Ltd, Unilever, ENOMARK BIOTECH (ENOMARK HEALTHCARE), Riaan Wellness Pvt. Ltd., Givaudan International SA (NATUREX S.A.), PLT Health Solutions, and INDENA S.P.A.

Key Findings of the Study

  • On the basis of source, the ashwagandha segment dominated the Adaptogens Marketin the year 2021.
  • On the basis of end use, the capsules segment is likely to be the fastest growing segment with a CAGR of 9.6% during the forecast period.
  • On the basis of application, dietary and sports supplements segment is likely to be the fastest growing segment with a CAGR of 8.8% during the forecast period.
  • On the basis of distribution channels, the business to business is likely to be the fastest growing segment with a CAGR of 7.8% during the forecast period.
  • Region wise, Asia-Pacific dominated the global adaptogens market.

Companies Mentioned

  • Dabur India Ltd
  • Emami Limited
  • kairali ayurvedic group
  • Himalaya Wellness
  • Colgate-Palmolive Company
  • Procter & Gamble
  • Patanjali Ayurved Limited
  • Shahnaz Ayurveda Pvt. Ltd.
  • Shree Baidyanath Ayurveda Bhawan Pvt. Ltd
  • Unilever
  • ENOMARK BIOTECH (ENOMARK HEALTHCARE)
  • Riaan Wellness Pvt. Ltd.
  • .Givaudan International SA (NATUREX S.A.)
  • PLT Health Solutions
  • INDENA S.P.A

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...